Berner Augenklinik am Lindenhofspital

Recent papers from Berner Augenklinik am Lindenhofspital

1. Foveal Avascular Zone and Its Associations – An Analysis Using OCTA: Results From the Gutenberg Health StudyTranslational Vision Science & Technology · 2026
2. From innovation to integration: what German mental health professionals think about peer-led youth discovery collegesEuropean Child & Adolescent Psychiatry · 2026
3. Predictors for non-response to PROMs across three areas of inpatient rehabilitation – a nationwide cross-sectional study in SwitzerlandJournal of Patient-Reported Outcomes · 2026
4. Custom-made anterior chamber intraocular lens for aphakia: a case reportBMC Ophthalmology · 2026
5. ACL rehabilitation after reconstruction: Evidence‐based consensus recommendations from the German Knee Society—Part IVJournal of Experimental Orthopaedics · 2026
6. Intraoperative landmarking errors and their avoidance in robotic‐assisted total knee arthroplasty using the VELYS systemJournal of Experimental Orthopaedics · 2026
7. Effect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval ExtensionOphthalmology Retina · 2026
8. Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network ReportOphthalmology and Therapy · 2026
9. Laxity phenotyping in total knee arthroplasty: A current concept articleKnee Surgery Sports Traumatology Arthroscopy · 2026
10. Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea studyScientific Reports · 2026
11. Optimizing Fracture Care in Children Using Biodegradable Magnesium Screws: Healing and Complications During Fixation With Magnesium Screws – A Retrospective Pilot StudyBritish journal of surgery · 2026
12. One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportOphthalmology and Therapy · 2026
13. One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportOphthalmology and Therapy · 2026
14. First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network reportBMJ Open Ophthalmology · 2026
15. Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network ReportOphthalmology Science · 2026
16. Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea StudyScientific Reports · 2026
17. Proliferative Diabetic Retinopathy in Young-Onset Type 1 Diabetes in Croatia: Risk Factors and a Predictive Economic Model for National ScreeningMedicina · 2025
18. A Community-Engaged Approach to Develop and Implement a Behavioral Infant Obesity Prevention Program for Marginalized Families in Home VisitingFamily & Community Health · 2025
19. Recovery of the Pupillary Response After Light Adaptation Is Slowed in Patients with Age-Related Macular DegenerationJournal of Eye Movement Research · 2025
20. Recovery of the Pupillary Response After Light Adaptation Is Slowed in Patients with Age-Related Macular DegenerationJournal of Eye Movement Research · 2025